Current Cancer Drug Targets,volume 18,issue 4  (04-2018)

Period of time： 2018年4期

Publisher： Bentham Science Publishers

Founded in： 2001

Total resources： 135

E-ISSN： 1873-5576|18|4

ISSN： 1568-0096

Subject： R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Current Cancer Drug Targets,volume 18,issue 4

Menu

Meet Our Editorial Board Member

Current Cancer Drug Targets,volume 18,issue 4 , Vol. 18, Iss. 4, 2018-04 , pp. 305-305

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Recent Updates on the Therapeutic Potential of HER2 Tyrosine Kinase Inhibitors for the Treatment of Breast Cancer

Current Cancer Drug Targets,volume 18,issue 4 , Vol. 18, Iss. 4, 2018-04 , pp. 306-327

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Involvement of CD24 in Multiple Cancer Related Pathways Makes It an Interesting New Target for Cancer Therapy

Current Cancer Drug Targets,volume 18,issue 4 , Vol. 18, Iss. 4, 2018-04 , pp. 328-336

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Synthetic Lethality: From Research to Precision Cancer Nanomedicine

Current Cancer Drug Targets,volume 18,issue 4 , Vol. 18, Iss. 4, 2018-04 , pp. 337-346

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Cell-derived Exosomes as Promising Carriers for Drug Delivery and Targeted Therapy

Current Cancer Drug Targets,volume 18,issue 4 , Vol. 18, Iss. 4, 2018-04 , pp. 347-354

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

The PI3K Pathway at the Crossroads of Cancer and the Immune System: Strategies for Next Generation Immunotherapy Combinations

Current Cancer Drug Targets,volume 18,issue 4 , Vol. 18, Iss. 4, 2018-04 , pp. 355-364

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Chemosensitizing Activity of Histone Deacetylases Inhibitory Cyclic Hydroxamic Acids for Combination Chemotherapy of Lymphatic Leukemia

Current Cancer Drug Targets,volume 18,issue 4 , Vol. 18, Iss. 4, 2018-04 , pp. 365-371

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

DNA Fragmentation, Cell Cycle Arrest, and Docking Study of Novel Bis Spiro-cyclic 2-oxindole of Pyrimido[4,5-b]quinoline-4,6-dione Derivatives Against Breast Carcinoma

Current Cancer Drug Targets,volume 18,issue 4 , Vol. 18, Iss. 4, 2018-04 , pp. 372-381

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

FOXP2 Promotes Tumor Proliferation and Metastasis by Targeting GRP78 in Triple-negative Breast Cancer

Current Cancer Drug Targets,volume 18,issue 4 , Vol. 18, Iss. 4, 2018-04 , pp. 382-389

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Neoisoliquiritigenin Inhibits Tumor Progression by Targeting GRP78-β- catenin Signaling in Breast Cancer

Current Cancer Drug Targets,volume 18,issue 4 , Vol. 18, Iss. 4, 2018-04 , pp. 390-399

Bentham Science Publishers

Abstract Access to resources Recommend Favorite

Total 10 item(s)